A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...

For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

Groundbreaking scientific research reveals the incredible connection between gut bacteria and stress responses, offering new hope for mental health treatment.

Addiction is more than just a habit—it’s a powerful force that rewires the brain, making it increasingly difficult to break free. Behavioral scientist Dr. Gino Collura joined ...

The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

Ketamine-assisted psychotherapy (KAP) uses low doses of ketamine alongside psychotherapy to treat mental health conditions.